SU1296156A1 - Method of healing wounds - Google Patents
Method of healing wounds Download PDFInfo
- Publication number
- SU1296156A1 SU1296156A1 SU853854928A SU3854928A SU1296156A1 SU 1296156 A1 SU1296156 A1 SU 1296156A1 SU 853854928 A SU853854928 A SU 853854928A SU 3854928 A SU3854928 A SU 3854928A SU 1296156 A1 SU1296156 A1 SU 1296156A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- days
- insulator
- treatment
- patient
- order
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение сокращает сроки лечени ран. Перед началом гипербарической оксигенации на поврежденном участке тела больного герметично закрепл ют гнотобиологический- изол тор , где привод т лечение, затем помещают больного вместе с изол тором в барокамеру и провод т оксигенацио при давлении 1,8-2,0 ата. В дальнейшем продолжают лечение в изол торе , до полного выздоровлени .The invention shortens the healing time of wounds. Before starting hyperbaric oxygenation, a gnetobiological insulator is sealed in the damaged part of the patient's body, where the treatment is brought, then the patient is placed together with the insulator in a pressure chamber and oxygenated at a pressure of 1.8-2.0 am. In the future, continue treatment in the isolator until full recovery.
Description
-.-.
Изобретение относитс к медицине, в частности к терапии.This invention relates to medicine, in particular to therapy.
Цель изобретени - сокращение сроков лечени за счет обеспечени стерильности , предотвращени реинфици- ровани и создани в ткан х раны достаточного содержани кислорода.The purpose of the invention is to reduce the treatment time by providing sterility, preventing reinfection, and creating sufficient oxygen in the wound tissue.
Способ осуществл ют следующим образом .The method is carried out as follows.
Перед началом гипербарической оксигенации на поврежденном участке тела больного герметично закрепл ют изол тор, например, из поливинилхло- ридной пленки, в котором создают стерильные услови и провод т лече- ние. Затем, дополнительно помещают больного вместе с изол тором в барокамеру и провод т сеанс гипербарической 1 оксигенации ; при давлении кислорода 1,8-2,0 ата. Между сеансами лечение раны в стерильной газовой среде продолжают в течение всего курса лечени .Before starting hyperbaric oxygenation, an isolator, for example, made of a polyvinyl chloride film, in which sterile conditions are created and treated, is hermetically sealed on the damaged part of the patient's body. Then, the patient is additionally placed together with the isolator in a pressure chamber and a session of hyperbaric 1 oxygenation is carried out; with oxygen pressure 1.8-2.0 at. Between the sessions, wound treatment in a sterile gas environment is continued throughout the entire course of treatment.
Пример 1. Больна Г. 5 лет поступила с диагнозом: обширна ушиб ленно сйальпированна рана левого бедра и правой голени, рана левой верхней конечности, открытый мета- эпифизиолиз левой болывеберцовой кости, перелом костей правой голени, продольный перелом правой п точной кости, перелом костей таза, сотр сение головного мозга.Example 1. Sick G. was admitted with a diagnosis of 5 years: extensive bruised sialpirovanny wound of the left hip and right tibia, wound of the left upper extremity, open meta-epiphyphysiolysis of the left tibial bone, fracture of the right tibia, fracture of the right right bone, bone fracture pelvis, brain loss.
Раны на верхней конечности, левом бедре и правой голени обработа- ны. Каждый лоскут на правой голени имел бледно-синюшньй цвет, что свидетельствовало о резких нарушени х его трофики. Дл предотвращени реин фицировани раны на правую нижнюю конечность накладывают местный гното биологический изол тор. Несмотр на комплекс проводимой терапии, сохранились выраженные нарушени трофики пересаженного кожного лоскута. С целью улучшени питани лоскутов болной провод т 5 сеансов гипербарической оксигенации без прекращени гно- тобиологической изол ции. Сеанс провод т при 1,8 ата в течение АО мин. При этом в гнотобиологическом изол тре посто нно поддерживают избыточное давление кислорода в 10 см водного столба. После 1-го сеанса исчезла синюпшость лоскута, по вилась его гипереми , увеличилось количество отдел емого из насечек. До и после сеанса провод т пол рографию, при которой отмечают повышение напр жени кислорода в пересаженной коже в 3-4 раза, что свидетельствует о сохранении жизнеспособности кожного лоскута. К 5-му сеансу отмечают стойкую гиперемию лоскута между сеансами , в св зи с чем прекращают лечение В дальнейшем ребенок продолжал лечитс в изол торе до полного выздоровлени . Некроза кожи и нагноение раны не отмечалось.The wounds on the upper limb, left thigh and right lower leg are treated. Each flap on the right tibia had a pale bluish color, which indicated sharp violations of its trophism. To prevent the wound from being reinfused, a local insulator biological insulator is placed on the right lower extremity. In spite of the complex of therapy being carried out, pronounced disorders of the trophism of the transplanted skin graft remained. In order to improve the nutrition of the disease flaps, 5 sessions of hyperbaric oxygenation have been carried out without stopping the biothobiological isolation. The session is carried out at 1.8 AT for AO minutes. At the same time, an excess oxygen pressure of 10 cm of water column is constantly maintained in the gnotobiological insulator. After the 1st session, the cyanosis of the flap disappeared, appeared in its hyperemia, the number of detachable from incisions increased. A polarization is carried out before and after the session, at which an increase in the oxygen pressure in the transplanted skin is noted by a factor of 3–4, which indicates that the skin flap remains viable. By the 5th session, persistent hyperemia of the flap between the sessions is noted, and therefore treatment is stopped. Subsequently, the child continued to be treated in the insulator until complete recovery. Necrosis of the skin and wound suppuration was not observed.
Пример 2, Больн ой К. 8 лет поступил с диагнозом: обширна скальпированна рана правой голени, шок 1-2 степени. Рана обработана с пластиков кожного лоскута. В последующем отмечалось нарушение трофики кожного лоскута, о чем свидетельствовала бледность и синюшньй оттенок его. Дл предотвращени реинфицировани накладьшают местный гнотобиологичес- кий изол тор. С целью улучшени приживлени кожного лоскута примен ют лечение в барокамере в сочетании с местной изол цией, дл чего больного вместе с изол тором помещают в барокамеру , где создают давление кислорода до 2,0 ата. Всего провод т 3 сеанса. После 1-го сеанса отмечают изчезновение синюшности лоскута и его гиперемию. После 3-х сеансов кожный лоскут полностью порозовел, что говорит о его приживлении. В дальнейшем лечение продолжают в услови х местной изол ции. Нагноение и некроза кожного лоскута не было.Example 2, Patient K., 8 years old, was admitted with a diagnosis: extensive scalped wound of the right tibia, shock 1-2 degrees. The wound is treated with plastics of the skin flap. Subsequently, a violation of the trophism of the skin graft was noted, as evidenced by the pallor and bluish tint of it. To prevent reinfection, a local gnobiological insulator is superimposed. In order to improve engraftment of the skin flap, treatment in the pressure chamber is used in combination with local isolation, for which the patient and the isolator are placed in a pressure chamber where oxygen pressure up to 2.0 atm is created. A total of 3 sessions were conducted. After the 1st session, the disappearance of the cyanosis of the flap and its hyperemia are noted. After 3 sessions, the skin flap completely turned pink, which indicates its engraftment. Further treatment is continued under local isolation. Suppuration and necrosis of the skin flap was not.
Таким образом, сочетание гипербарической оксигенации и местной гнотобиологической изол ции приводит к устранению плтоксии в ткан х, на- сьпцению их кислородом и предотвращению инфицировани и реинфицировани .Thus, the combination of hyperbaric oxygenation and local biotoxic isolation leads to the elimination of pltoxia in tissues, oxygen saturation and the prevention of infection and reinfection.
В среднем на курс лечени необходимо 8 сеансов.On average, 8 treatments are needed per course of treatment.
Эффективность предлагаемого способа представлена в таблице.The effectiveness of the proposed method is presented in the table.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU853854928A SU1296156A1 (en) | 1985-02-14 | 1985-02-14 | Method of healing wounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU853854928A SU1296156A1 (en) | 1985-02-14 | 1985-02-14 | Method of healing wounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1296156A1 true SU1296156A1 (en) | 1987-03-15 |
Family
ID=21162582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU853854928A SU1296156A1 (en) | 1985-02-14 | 1985-02-14 | Method of healing wounds |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1296156A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062500B2 (en) | 2001-12-05 | 2011-11-22 | Oculus Innovative Sciences, Inc. | Method and apparatus for producing negative and positive oxidative reductive potential (ORP) water |
US8147444B2 (en) | 2006-01-20 | 2012-04-03 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
US8323252B2 (en) | 2005-03-23 | 2012-12-04 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
US9498548B2 (en) | 2005-05-02 | 2016-11-22 | Oculus Innovative Sciences, Inc. | Method of using oxidative reductive potential water solution in dental applications |
US10342825B2 (en) | 2009-06-15 | 2019-07-09 | Sonoma Pharmaceuticals, Inc. | Solution containing hypochlorous acid and methods of using same |
-
1985
- 1985-02-14 SU SU853854928A patent/SU1296156A1/en active
Non-Patent Citations (1)
Title |
---|
Авторское свидетельство СССР №578971, кл. А 61 М 15/02, 1976. * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062500B2 (en) | 2001-12-05 | 2011-11-22 | Oculus Innovative Sciences, Inc. | Method and apparatus for producing negative and positive oxidative reductive potential (ORP) water |
US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
US9642876B2 (en) | 2003-12-30 | 2017-05-09 | Sonoma Pharmaceuticals, Inc. | Method of preventing or treating sinusitis with oxidative reductive potential water solution |
US10016455B2 (en) | 2003-12-30 | 2018-07-10 | Sonoma Pharmaceuticals, Inc. | Method of preventing or treating influenza with oxidative reductive potential water solution |
US8323252B2 (en) | 2005-03-23 | 2012-12-04 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
US8840873B2 (en) | 2005-03-23 | 2014-09-23 | Oculus Innovative Sciences, Inc. | Method of treating second and third degree burns using oxidative reductive potential water solution |
US9498548B2 (en) | 2005-05-02 | 2016-11-22 | Oculus Innovative Sciences, Inc. | Method of using oxidative reductive potential water solution in dental applications |
US8147444B2 (en) | 2006-01-20 | 2012-04-03 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
US8834445B2 (en) | 2006-01-20 | 2014-09-16 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
US9072726B2 (en) | 2006-01-20 | 2015-07-07 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
US9782434B2 (en) | 2006-01-20 | 2017-10-10 | Sonoma Pharmaceuticals, Inc. | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
US10342825B2 (en) | 2009-06-15 | 2019-07-09 | Sonoma Pharmaceuticals, Inc. | Solution containing hypochlorous acid and methods of using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1296156A1 (en) | Method of healing wounds | |
ATE131064T1 (en) | TREATMENT TO REDUCE EDEMA AND MUSCLE DAMAGE. | |
MX157054A (en) | PROCEDURE FOR PREPARING DERIVATIVES OF DISENZOXAZEPINE | |
Pike et al. | Studies in resuscitation: I. The general conditions affecting resuscitation, and the resuscitation of the blood and of the heart | |
Horsley | Address in surgery: delivered at the seventy-fourth annual meeting of the British Medical Association | |
Wallace | Surgery at a casualty clearing station | |
JPS63188391A (en) | Production of substance useful for bacteria destruction and/or immune regulation | |
Kofoed et al. | Myonecrotic gas gangrene of the extremities | |
Cheyne | Antiseptic surgery | |
Edgar | Modern surgery and Lord Lister | |
Gibson | The Carrel method of treating wounds | |
Dambe et al. | 193. Zeitpunkt, Anaesthesieverfahren und Versorgungsmodus hüftgelenksnaher Frakturen im Senium | |
SU1220648A1 (en) | Method of treatment of chronic osteomyelitis | |
BAKER et al. | REGIONAL PERFUSION FOR CONTROL OF ACUTE HEMOLYTIC STREPROCOCCAL GANGRENE: A CASE REPORT | |
RU2203078C2 (en) | Method for treating suppurating wounds | |
RU2134134C1 (en) | Method for preparing transplant to carry out open autodermatoplasty of burn wound | |
RU1832021C (en) | Method and apparatus for treating wounds and trophic ulcers | |
RU2214825C2 (en) | Method for introducing ozone- containing medicinal substances into the body | |
RU2092121C1 (en) | Method for auto- and homoplastic skin transplantation | |
SU1509044A1 (en) | Method of treatment of neuralgia of trigeminal nerve | |
SU1748826A1 (en) | Method for treating inflammatory diseases of skin and mucous membranes | |
SU1189432A1 (en) | Method of free autodermoplasty | |
Leriche | The Listerian Idea in 1939 | |
Da Costa | A manual of modern surgery | |
RU2214188C2 (en) | Method for preparing receiving bed to make cutanoplastic repair |